These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


87 related items for PubMed ID: 19940490

  • 1. Natural history of growth and body composition in juvenile idiopathic arthritis.
    Bechtold S, Roth J.
    Horm Res; 2009 Nov; 72 Suppl 1():13-9. PubMed ID: 19940490
    [Abstract] [Full Text] [Related]

  • 2. Growth abnormalities in children and adolescents with juvenile idiopathic arthritis.
    Bechtold S, Simon D.
    Rheumatol Int; 2014 Nov; 34(11):1483-8. PubMed ID: 24760485
    [Abstract] [Full Text] [Related]

  • 3. Linear growth and final height in patients with systemic juvenile idiopathic arthritis treated with longterm glucocorticoids.
    Simon D, Fernando C, Czernichow P, Prieur AM.
    J Rheumatol; 2002 Jun; 29(6):1296-300. PubMed ID: 12064849
    [Abstract] [Full Text] [Related]

  • 4. Linear growth in children suffering from juvenile idiopathic arthritis requiring steroid therapy: natural history and effects of growth hormone treatment on linear growth.
    Simon D, Lucidarme N, Prieur AM, Ruiz JC, Czernichow P.
    J Pediatr Endocrinol Metab; 2001 Jun; 14 Suppl 6():1483-6. PubMed ID: 11837503
    [Abstract] [Full Text] [Related]

  • 5. Management of growth retardation in juvenile idiopathic arthritis.
    Simon D.
    Horm Res; 2007 Jun; 68 Suppl 5():122-5. PubMed ID: 18174727
    [Abstract] [Full Text] [Related]

  • 6. Effects of growth hormone treatment in juvenile idiopathic arthritis: bone and body composition.
    Bechtold S, Dalla Pozza R, Schwarz HP, Simon D.
    Horm Res; 2009 Nov; 72 Suppl 1():60-4. PubMed ID: 19940498
    [Abstract] [Full Text] [Related]

  • 7. Etanercept treatment improves longitudinal growth in prepubertal children with juvenile idiopathic arthritis.
    Vojvodich PF, Hansen JB, Andersson U, Sävendahl L, Hagelberg S.
    J Rheumatol; 2007 Dec; 34(12):2481-5. PubMed ID: 18050366
    [Abstract] [Full Text] [Related]

  • 8. Adult outcomes of patients with juvenile idiopathic arthritis.
    Minden K.
    Horm Res; 2009 Nov; 72 Suppl 1():20-5. PubMed ID: 19940491
    [Abstract] [Full Text] [Related]

  • 9. Effect of inflammatory activity and glucocorticoid [corrected] use on nutritional variables in patients with juvenile idiopathic arthritis.
    Souza L, Machado SH, Bredemeier M, Brenol JC, Xavier RM.
    J Rheumatol; 2006 Mar; 33(3):601-8. PubMed ID: 16511929
    [Abstract] [Full Text] [Related]

  • 10. A two-year prospective controlled study of bone mass and bone turnover in children with early juvenile idiopathic arthritis.
    Lien G, Selvaag AM, Flatø B, Haugen M, Vinje O, Sørskaar D, Dale K, Egeland T, Førre Ø.
    Arthritis Rheum; 2005 Mar; 52(3):833-40. PubMed ID: 15751052
    [Abstract] [Full Text] [Related]

  • 11. Effects of growth hormone treatment on growth in children with juvenile idiopathic arthritis.
    Simon D, Bechtold S.
    Horm Res; 2009 Nov; 72 Suppl 1():55-9. PubMed ID: 19940497
    [Abstract] [Full Text] [Related]

  • 12. [Relationship between bone mineral content and growth disorders in children with juvenile idiopathic arthritis].
    Górska A, Urban M, Konstantynowicz J, Bartnicka M, Chlabicz S, Górski S, Kaczmarski M.
    Pol Merkur Lekarski; 2008 Mar; 24(141):227-30. PubMed ID: 18634288
    [Abstract] [Full Text] [Related]

  • 13. Growth hormone improves height in patients with juvenile idiopathic arthritis: 4-year data of a controlled study.
    Bechtold S, Ripperger P, Häfner R, Said E, Schwarz HP.
    J Pediatr; 2003 Oct; 143(4):512-9. PubMed ID: 14571231
    [Abstract] [Full Text] [Related]

  • 14. Age at menarche in juvenile rheumatoid arthritis.
    Rusconi R, Corona F, Grassi A, Carnelli V.
    J Pediatr Endocrinol Metab; 2003 Mar; 16 Suppl 2():285-8. PubMed ID: 12729405
    [Abstract] [Full Text] [Related]

  • 15. Visual outcomes in children with juvenile idiopathic arthritis-associated uveitis.
    Kump LI, Castañeda RA, Androudi SN, Reed GF, Foster CS.
    Ophthalmology; 2006 Oct; 113(10):1874-7. PubMed ID: 16884776
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type.
    Quartier P, Taupin P, Bourdeaut F, Lemelle I, Pillet P, Bost M, Sibilia J, Koné-Paut I, Gandon-Laloum S, LeBideau M, Bader-Meunier B, Mouy R, Debré M, Landais P, Prieur AM.
    Arthritis Rheum; 2003 Apr; 48(4):1093-101. PubMed ID: 12687553
    [Abstract] [Full Text] [Related]

  • 17. Etanercept improves linear growth and bone mass acquisition in MTX-resistant polyarticular-course juvenile idiopathic arthritis.
    Billiau AD, Loop M, Le PQ, Berthet F, Philippet P, Kasran A, Wouters CH.
    Rheumatology (Oxford); 2010 Aug; 49(8):1550-8. PubMed ID: 20444859
    [Abstract] [Full Text] [Related]

  • 18. Clinical significance of decreased serum concentration of cartilage oligomeric matrix protein in systemic juvenile idiopathic arthritis.
    Urakami T, Manki A, Inoue T, Oda M, Tanaka H, Morishima T.
    J Rheumatol; 2006 May; 33(5):996-1000. PubMed ID: 16652429
    [Abstract] [Full Text] [Related]

  • 19. Frequency of osteopenia in adolescents with early-onset juvenile idiopathic arthritis: a long-term outcome study of one hundred five patients.
    Lien G, Flatø B, Haugen M, Vinje O, Sørskaar D, Dale K, Johnston V, Egeland T, Førre Ø.
    Arthritis Rheum; 2003 Aug; 48(8):2214-23. PubMed ID: 12905475
    [Abstract] [Full Text] [Related]

  • 20. Bone mass development and bone metabolism in juvenile idiopathic arthritis: treatment with growth hormone for 4 years.
    Bechtold S, Ripperger P, Bonfig W, Schmidt H, Bitterling H, Häfner R, Schwarz HP.
    J Rheumatol; 2004 Jul; 31(7):1407-12. PubMed ID: 15229964
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.